• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

How Concerning Is Pfizer and Opko's Latest FDA Rejection?

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 03, 2022 at 11:22: PM
via The U.S. Food and Drug Administration (FDA) recently refused to approve Pfizer's (NYSE: PFE) and Opko Health's (NASDAQ: OPK) growth hormone therapy, somatrogon. In this Motley Fool Live video, recorded on Jan. 26, Motley Fool contributors Keith Speights and Brian Orelli discuss how concerning this rejection is for the two companies.

article source
 




Top Bottom
Back
Quote